✦ LIBER ✦

Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design

✍ Scribed by Cheng, Hengmiao; Bagrodia, Shubha; Bailey, Simon; Edwards, Martin; Hoffman, Jacqui; Hu, Qiyue; Kania, Robert; Knighton, Daniel R.; Marx, Matthew A.; Ninkovic, Sacha

Book ID: 115456821
Publisher: The Royal Society of Chemistry
Year: 2010
Tongue: English
Weight: 274 KB
Volume: 1
Category: Article
ISSN: 2040-2503
DOI: 10.1039/c0md00072h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical evaluation of the PI3K-mTOR

Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma

✍ Wong, Chi Hang; Loong, Herbert H.; Hui, Connie W. C.; Lau, Cecilia P. Y.; Hui, E 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 440 KB

[RSC Drug Discovery] Designing Multi-Tar

[RSC Drug Discovery] Designing Multi-Target Drugs Volume 654 || Chapter 13. Identification and Optimization of Dual PI3K/mTOR Inhibitors

✍ Morphy, J. Richard; Harris, C John 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 671 KB

BCX-1812 (RWJ-270201): Discovery of a No

BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

✍ Babu, Y. Sudhakar; Chand, Pooran; Bantia, Shanta; Kotian, Pravin; Dehghani, Ali; 📂 Article 📅 2000 🏛 American Chemical Society 🌐 English ⚖ 363 KB

358 A Multi-arm Phase 1 Dose Escalation

358 A Multi-arm Phase 1 Dose Escalation Study of Safety, Pharmacokinetics, and Pharmacodynamics of the Dual PI3K/mTOR Inhibitors PF-04691502 (oral) and PF-05212384 (IV) in Combination with the MEK Inhibitor PD-0325901 or Irinotecan in Patients with Advanced Cancer

✍ Britten, C.; Wainberg, Z.; Tabernero, J.; Alsina Maqueda, M.; Leong, S.; Sessa, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

ChemInform Abstract: BCX-1812 (RWJ-27020

ChemInform Abstract: BCX-1812 (RWJ-270201) (I): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor Through Structure-Based Drug Design.

✍ Y. Sudhakar Babu; et al. et al. 📂 Article 📅 2001 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views

Identification of Potent and Selective S

Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design

✍ DeLano, Warren L.; Fahr, Bruce; Choong, Ingrid C.; Lew, Willard; Lee, Dennis; Ph 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 651 KB